December 23, 2015
Eli Lilly relies on The Chase Group once more for the recruitment of a physician to join their Breast Cancer Team. Lilly has an FDA designated breakthrough drug for breast cancer, and this physician will play a crucial role in analyzing the data from three pivotal studies and moving the compound through the global regulatory process. To learn more about The Chase Group’s strength in securing leadership talent, contact us at chase@chasegroup.com.
